Cancer Genome Project

From Wikipedia, the free encyclopedia
Jump to: navigation, search

The Cancer Genome Project, based at the Wellcome Trust Sanger Institute, aims to identify sequence variants/mutations critical in the development of human cancers. Like The Cancer Genome Atlas project within the United States, the Cancer Genome Project represents an effort in the War on Cancer to improve cancer diagnosis, treatment, and prevention through a better understanding of the molecular basis of this disease.

The Cancer Genome Project, led by Michael Stratton and Peter Campbell,[1] combines knowledge of the human genome sequence with high throughput mutation detection techniques.

See also[edit]

External links[edit]


  1. ^ Peter Campbell
  2. ^
  3. ^